Orum Therapeutics, Inc. (KOSDAQ:475830)
130,300
+3,700 (2.92%)
At close: Feb 27, 2026
284.37% (1Y)
| Market Cap | 2.77T |
| Revenue (ttm) | 25.48M -100.0% |
| Net Income | -36.88B |
| EPS | -2,048.17 |
| Shares Out | 21.23M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 632,243 |
| Average Volume | 332,485 |
| Open | 124,600 |
| Previous Close | 126,600 |
| Day's Range | 123,900 - 132,800 |
| 52-Week Range | 15,950 - 146,600 |
| Beta | n/a |
| RSI | 58.77 |
| Earnings Date | Mar 20, 2026 |